Overview of Dr. Monge Urrea
Plasma Cell Disorders,
Autologous Stem Cell Transplantation and Cellular Therapy
Office
Uchealth Hematology Clinic Anschutz Medical Campus 1665 Aurora Court Anschutz Cancer Pavilion
3rd Floor
Aurora, CO 80045Fax+1 720-848-1786
Education & Training
- Universidad Anahuac School of MedicineClass of 2011
Certifications & Licensure
- CO State Medical License 2024 - 2025
- CT State Medical License 2024 - 2024
- NY State Medical License 2017 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Scott Wadler Memorial Fellow Clinical Research Award Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medical College, 2020
- 5 time recipient of the Academic Excellence Award Universidad Anahuac, 2004-2008
- Outstanding Performance Award CENEVAL
Clinical Trials
- Treatment of Selinexor in Combination With Clarithromycin, Pomalidomide and Dexamethasone for Relapsed Refractory Multiple Myeloma Patients Start of enrollment: 2021 Dec 29
- A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS) Start of enrollment: 2023 Oct 16
- Carfilzomib, Clarithromycin (Biaxin®), Lenalidomide (Revlimid®), and Dexamethasone (Decadron®) [Car-BiRD] Therapy for Subjects With Multiple Myeloma Start of enrollment: 2012 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsExploring health disparities in diagnosing multiple myeloma.Nima Ghalehsari, Sofia Zahid, Olivia Main, Soeb Usta, John Patresan
Expert Review of Hematology. 2024-10-01 - 1 citationsAbsolute lymphocyte count after BCMA CAR-T therapy is a predictor of response and outcomes in relapsed multiple myeloma.Mateo Mejia Saldarriaga, Darren Pan, Caitlin Unkenholz, Tarek H Mouhieddine, Juan Esteban Velez-Hernandez
Blood Advances. 2024-08-13 - 2 citationsCurrent landscape of CD3 bispecific antibodies in hematologic malignancies.Joshua Kassner, Basma Abdellatif, Samuel Yamshon, Jorge Monge, Justin Kaner
Trends in Cancer. 2024-08-01
Journal Articles
- Predicting multiple myeloma disease activity by analyzing natural calcium isotopic compositionGordon GW, Monge J, Channon MB, Wu Q, Skulan JL, Anbar AD, Fonseca R, Leukemia, 1/1/2014
- Sudden cardiac arrest at the finish line: in coronary ectopia, the cause of ischemia is from intramural course, not ostial locationJoggerst S, Monge J, Uribe C, Sherron S, Angelini P, Tex Heart Inst J, 1/1/2014
- Staging and prognostication of multiple myelomaFonseca R, Monge J, Dimopoulos MA, Expert Rev Hematol, 1/1/2014
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Harnessing the Epichaperome As a Therapeutic Approach in Multiple MyelomaJorge Monge, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Cyclophosphamide, bortezomib, and dexamethasone (CYBORD) treatment for relapsed/refractory multiple myelomaMonge J, Kortum KM, Stewart AK, Bergsagel PL, Mikhael J, Reeder CB, Mayo A, Fonseca R, J Clin Oncol, 1/1/2014
- Calcium Isotopic Composition and Its Association With Multiple Myeloma Disease ActivityGordon GW, Monge J, Channon MB, Wu Q, Skulan JL, Anbar AD, Fonseca R, Blood, 1/1/2013
- Join now to see all
Professional Memberships
- Member
- Member
- International Myeloma SocietyMember
- International Myeloma Working GroupMember
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: